Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Blier

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
The International Journal of Neuropsychopharmacology|April 2, 2015
A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant DepressionJennifer L Phillips, Lisa A Batten, Philippe Tremblay, et al.
The International Journal of Neuropsychopharmacology|April 1, 2026
Structural and functional neuroimaging correlates of suicidal ideation in treatment-resistant major depressive disorderPatricia Burhunduli, Katie L Vandeloo, Zhuo Fang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2016
Inverse agonists - What do they mean for psychiatry?David Nutt, Stephen Stahl, Pierre Blier, et al.
Psychiatry Research. Neuroimaging|June 2, 2020
Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorderSara de la Salle, Natalia Jaworska, Pierre Blier, et al.
The American Journal of Psychiatry|December 17, 2009
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized studyPierre Blier, Herbert E Ward, Philippe Tremblay, et al.
Frontiers in Psychiatry|January 30, 2019
Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical DataNatalia Jaworska, Sara de la Salle, Mohamed-Hamza Ibrahim, et al.
The Journal of Clinical Psychiatry|August 6, 2009
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover studyFranck Chenu, Lisa A Batten, Gerald Zernig, et al.
Molecular Pharmacology|October 17, 2018
Involvement of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> Receptors but Not <i>α</i> <sub>2</sub>-Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain In VivoAnna Herman, Mostafa El Mansari, Nika Adham, et al.
The International Journal of Neuropsychopharmacology|May 13, 2006
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteersPierre Blier, Elise Saint-André, Chantal Hébert, et al.
The International Journal of Neuropsychopharmacology|May 13, 2006
Differential physiological effects of a low dose and high doses of venlafaxine in major depressionGuy Debonnel, Elise Saint-André, Chantal Hébert, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
The International Journal of Neuropsychopharmacology|April 2, 2015
A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant DepressionJennifer L Phillips, Lisa A Batten, Philippe Tremblay, et al.
The International Journal of Neuropsychopharmacology|April 1, 2026
Structural and functional neuroimaging correlates of suicidal ideation in treatment-resistant major depressive disorderPatricia Burhunduli, Katie L Vandeloo, Zhuo Fang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 14, 2016
Inverse agonists - What do they mean for psychiatry?David Nutt, Stephen Stahl, Pierre Blier, et al.
Psychiatry Research. Neuroimaging|June 2, 2020
Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorderSara de la Salle, Natalia Jaworska, Pierre Blier, et al.
The American Journal of Psychiatry|December 17, 2009
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized studyPierre Blier, Herbert E Ward, Philippe Tremblay, et al.
Frontiers in Psychiatry|January 30, 2019
Leveraging Machine Learning Approaches for Predicting Antidepressant Treatment Response Using Electroencephalography (EEG) and Clinical DataNatalia Jaworska, Sara de la Salle, Mohamed-Hamza Ibrahim, et al.
The Journal of Clinical Psychiatry|August 6, 2009
Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover studyFranck Chenu, Lisa A Batten, Gerald Zernig, et al.
Molecular Pharmacology|October 17, 2018
Involvement of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> Receptors but Not <i>α</i> <sub>2</sub>-Adrenoceptors in the Acute Electrophysiological Effects of Cariprazine in the Rat Brain In VivoAnna Herman, Mostafa El Mansari, Nika Adham, et al.
The International Journal of Neuropsychopharmacology|May 13, 2006
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteersPierre Blier, Elise Saint-André, Chantal Hébert, et al.
The International Journal of Neuropsychopharmacology|May 13, 2006
Differential physiological effects of a low dose and high doses of venlafaxine in major depressionGuy Debonnel, Elise Saint-André, Chantal Hébert, et al.
Pageof 23